LHQ766
LHQ766 is a highly selective and orally effective covalent FGFR2 inhibitor with an IC50 of 7.3 nM. It significantly inhibits the phosphorylation of FGFR2 and its downstream signaling molecules FRS2-a, Akt, and ERK1/2. LHQ766 selectively suppresses the proliferation of cancer cells driven by FGFR2.
Product Specifications
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog